Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI

This page shows the latest BenevolentAI news and features for those working in and with pharma, biotech and healthcare.

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

It joins a growing field of companies bringing AI and computational methods to accelerate R&D, including other UK-based companies such as BenevolentAI and Exscientia.

Latest news

  • BenevolentAI raises $115m to fund drug development BenevolentAI raises $115m to fund drug development

    BenevolentAI raises $115m to fund drug development. Its technology could cut the early stage drug discovery process by four years, says the company. ... UK artificial intelligence company BenevolentAI has raised $115m in a funding round that takes its

  • BenevolentAI claims AI first with new Cambridge facility BenevolentAI claims AI first with new Cambridge facility

    BenevolentAI claims AI first with new Cambridge facility. Says its new drug discovery and development base will cover the entire research process. ... Those employees will be integrated with BenevolentAI's own drug discovery scientists and tasked with

  • WE Communications wins BenevolentAI account WE Communications wins BenevolentAI account

    WE Communications wins BenevolentAI account. It will be tasked with raising the artificial intelligence firm's profile. ... WE Communications UK has been appointed by BenevolentAI to bolster its integrated communications and marketing efforts.

  • BenevolentAI expands its reach opening an office in New York BenevolentAI expands its reach opening an office in New York

    British artificial intelligence (AI) company BenevolentAI is expanding into the US, opening an office in New York. ... Meanwhile, BenevolentAI has hired Dr Ian Churcher as its new VP of drug discovery at its bioscience subsidiary BenevolentBio.

  • Artificial intelligence firm licenses Janssen candidates for development Artificial intelligence firm licenses Janssen candidates for development

    Artificial intelligence firm licenses Janssen candidates for development. UK-based BenevolentAI aims to move them into late-stage trials by mid-2017. ... BenevolentAI was founded in 2013 as a spin-out of pharmaceutical company Proximagen.

More from news
Approximately 5 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • BenevolentAI appoints new head of cheminformatics BenevolentAI appoints new head of cheminformatics

    BenevolentAI appoints new head of cheminformatics. Dr Nathan Brown joins from the Institute of Cancer Research. ... Artificial Intelligence (AI) group BenevolentAI has appointed Dr Nathan Brown as its new head of cheminformatics.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Infographics